You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myelogenous leukemia (CML) in blast crisis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Chronic Myeloid Leukemia in Myeloid Blast Crisis Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • Brno, Czechia
    • +8 more
    Jan 27, 2021

    Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2022

    Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

    Completed
    Has Results
    • Philadelphia Chromosome Positive CML
    • imatinib mesylate
    • Chicago, Illinois
    • +9 more
    Jun 3, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

    Terminated
    • Accelerated Phase Chronic Myelogenous Leukemia (CML)
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2020

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • Clofarabine 40mg/m^2
    • +5 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 3, 2020

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      Concomitant Medications at CML Diagnosis

      Completed
      • Chronic Myeloid Leukemia
      • the prevalence of comorbid conditions
      • (no location specified)
      Sep 16, 2023

      Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

      Recruiting
      • Acute Myeloid Leukemia
      • +6 more
      • Orca-Q
      • Gainesville, Florida
        University of Florida
      Aug 26, 2022

      Needs of 3L+ CP-CML and With T315I-mutated CML Patients

      Completed
      • Chronic Myeloid Leukemia
      • 3L Therapy
      • T315I
      • Lyon, France
        Novartis Investigative Site
      Nov 9, 2022

      Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

      Recruiting
      • Chronic Myelogenous Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 27, 2022

      Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

      Not yet recruiting
      • Tyrosine Kinase Inhibitors
      • Chronic Myeloid Leukemia
      • treatment of TKI in CML
      • Poitiers, France
        Chu Poitiers
      Feb 21, 2023

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023

      Chronic Myeloid Leukemia (CML) Trial in France

      Recruiting
      • Chronic Myeloid Leukemia (CML)
        • Annecy, France
        • +11 more
        Jul 18, 2023

        Ponatinib in CML Patients in Chronic Phase

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Therapeutic drug monitoring
        • Molecular Response
        • Cagliari, Italy
        • +4 more
        Nov 3, 2023

        CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

        Not yet recruiting
        • CML (Chronic Myelogenous Leukemia
        • (no location specified)
        Jul 27, 2022